Mechanism of Action

Vincristine (NSC-67574) sulfate belongs to the vinca alkaloid family, a group of bisindole natural products originally isolated from the periwinkle plant Catharanthus roseus. Its primary mechanism of action involves high-affinity binding to the vinca domain on β-tubulin subunits of the tubulin heterodimer. This interaction prevents the normal polymerization of αβ-tubulin dimers into microtubule protofilaments, effectively depolymerizing existing microtubules and blocking the formation of new ones.

As a consequence, vincristine disrupts the dynamic assembly of the mitotic spindle apparatus required for accurate chromosomal segregation during cell division. Cells treated with vincristine accumulate at the G2/M boundary and in metaphase, unable to complete mitosis. Prolonged mitotic arrest triggers the intrinsic apoptotic pathway, leading to programmed cell death predominantly in rapidly dividing cells. This selectivity for mitotically active cells underpins both its clinical utility and its widespread adoption as a research tool for dissecting cell-cycle regulation and apoptotic signaling.

Pharmacological Properties & Formulation

Vincristine sulfate is the water-soluble salt form of vincristine, enhancing its utility for aqueous-based experimental systems. It is typically supplied as a white to off-white lyophilized powder or solid. For research purposes, stock solutions are commonly prepared by dissolving the compound in sterile water or dimethyl sulfoxide (DMSO), yielding clear solutions suitable for cell culture or in vivo administration after appropriate dilution.

Key pharmacological characteristics relevant to researchers include its nanomolar to low-micromolar potency range in cellular assays, time- and concentration-dependent mitotic arrest, and its ability to synergize with DNA-damaging agents and other targeted therapies in combination studies. Researchers should note that vincristine exhibits narrow concentration windows between effective and cytotoxic doses in normal proliferating cells; therefore, careful dose-response optimization is recommended for each cell line or model system used.

Storage under recommended conditions (typically −20 °C, protected from light, desiccated) preserves compound integrity. Repeated freeze-thaw cycles should be minimized by preparing single-use aliquots from stock solutions.

Research Applications in Cancer Biology

Vincristine (NSC-67574) sulfate is extensively employed across a broad spectrum of cancer biology research contexts. Its well-characterized mechanism makes it an ideal positive control and mechanistic probe in the following experimental settings:

• Cell cycle analysis: Vincristine is routinely used to synchronize cell populations at mitosis. Treatment followed by release allows researchers to track cell-cycle progression and study checkpoint kinetics using flow cytometry (propidium iodide or BrdU/EdU staining) or live-cell imaging.
• Apoptosis and cell death assays: At cytotoxic concentrations, vincristine induces apoptosis that can be quantified by Annexin V/PI staining, caspase activation assays, or PARP cleavage immunoblotting, serving as a benchmark compound in drug-screening platforms.
• Drug combination studies: Researchers utilize vincristine as a backbone agent alongside kinase inhibitors, proteasome inhibitors, or immunotherapeutic agents to evaluate synergy or antagonism in hematological malignancy and solid tumor cell lines.
• In vivo tumor models: Vincristine sulfate is administered in xenograft or syngeneic mouse tumor models to assess antitumor efficacy, pharmacodynamic endpoints (mitotic index, γH2AX), and tolerability profiles in preclinical settings.
• Resistance mechanism studies: Acquisition of vincristine resistance is associated with overexpression of P-glycoprotein (MDR1/ABCB1) and other ABC transporters, making it a standard agent for multidrug resistance (MDR) research.

Experimental Protocol Guidelines

The following general guidelines are provided for research use. Researchers should optimize all conditions for their specific cell lines, model systems, and endpoints.

Stock solution preparation: Dissolve vincristine sulfate in sterile water or DMSO to a concentration of 1–10 mM. Vortex gently and warm to 37 °C briefly if needed to achieve complete dissolution. Filter-sterilize aqueous stocks through a 0.22 µm membrane before use in cell culture.

Working concentrations: Typical working concentrations for cell cycle synchronization range from 10–100 nM; cytotoxicity assays often employ a broader range (1 nM–10 µM) to establish IC50 values. Empirical dose-response experiments are recommended for each new cell model.

Cell treatment duration: For mitotic arrest, 12–24 hours of treatment is commonly employed. For apoptosis induction, 24–72 hours may be required depending on cell type and concentration.

Washout and release experiments: To synchronize cells and then release, wash treated cells at least twice with pre-warmed phosphate-buffered saline (PBS) and add fresh complete medium. Collect cells at defined time points post-release for downstream analyses.

Safety considerations: Vincristine sulfate is a potent cytotoxin. Handle with appropriate personal protective equipment (gloves, lab coat, eye protection) in a ventilated area. Dispose of all waste in accordance with institutional chemical waste disposal regulations.

Quality, Purity & Storage Specifications

Aladdin Scientific supplies vincristine (NSC-67574) sulfate (SKU: V408259) as a research-grade reagent. This product is also cross-referenced to Selleck catalog number S1241. Researchers and procurement personnel should confirm the certificate of analysis (CoA) for each lot, which typically includes purity determination by HPLC, identity confirmation by mass spectrometry or NMR, and appearance characterization.

Recommended storage conditions: Store at −20 °C in a desiccated, light-protected environment. Under these conditions, the compound is expected to remain stable for an extended period; however, researchers should verify stability data on the relevant CoA or product datasheet.

Handling after reconstitution: Once reconstituted, aliquot the solution into single-use volumes to prevent degradation from repeated freeze-thaw cycling. Aqueous solutions should be used promptly or stored at −20 °C for short-term use. DMSO solutions can be stored at −20 °C.

Quality assurance: Each batch undergoes quality control testing before release. Researchers with specific purity or formulation requirements should contact Aladdin Scientific's technical support team for custom specifications or bulk inquiries.